CVS researchers re-examine cholesterol treatments
WOONSOCKET, R.I. — CVS Health Research Institute experts have urged cardiologists to consider changing their treatment guidelines for patients with high cholesterol as a new class of high-cost medications arrives on the market. A commentary published online in the Journal of the American Medical Association on August 10 argued that the new cholesterol-lowering drugs, known
